ClearPoint Neuro prices $15M public offering of 2.3M shares at $6.50

ClearPoint Neuro, Inc.

Offering of 2,307,694 shares of common stock at $6.50 per share; underwriters have 30-day option for 346,154 additional shares.
Net proceeds expected to be approximately $14.0 million, or $16.2 million if over-allotment option fully exercised.
Proceeds to be used for general corporate purposes, including R&D, potential acquisitions, investments, or debt repayment.
Offering expected to close on or about March 4, 2024; Lake Street Capital Markets is lead underwriter.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.